Ivermectin against COVID-19: The unprecedented consequences in Latin America
- PMID: 33880395
- PMCID: PMC8050401
- DOI: 10.1016/j.onehlt.2021.100250
Ivermectin against COVID-19: The unprecedented consequences in Latin America
Keywords: Clinical pharmacology; Drug safety; Latin America; Macrocyclic lactone; One health; Virus.
References
-
- Ottesen E.A., Campbell W.C. Ivermectin in human medicine. J. Antimicrob. Chemother. 1994;34:195–203. - PubMed
-
- Perez-Garcia L.A., Mejias-Carpio I.E., Delgado-Noguera L.A., Manzanarez-Motezuma J.P., Escalona-Rodriguez M.A., Sordillo E.M., Mogollon-Rodriguez E.A., Hernandez-Pereira C.E., Marquez-Colmenarez M.C., Paniz-Mondolfi A.E. Ivermectin: repurposing a multipurpose drug for Venezuela’s humanitarian crisis. Int. J. Antimicrob. Ag. 2020;56:106037. doi: 10.1016/j.ijantimicag.2020.106037. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources